Wordt geladen...
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
Objectives: The aim of this study is to conduct an analysis on the regulation and application of managed entry agreements (MEA) for oncology drugs across different European countries. Methods: Literature search and document analysis were performed between September 2015 and June 2016 to collect info...
Bewaard in:
| Gepubliceerd in: | Front Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378787/ https://ncbi.nlm.nih.gov/pubmed/28420990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00171 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|